Skip to main content

Table 2 Summary statistics from meta-analyses of prevalence studies on HCV infection among β-thalassemia patients residing in Pakistan

From: The prevalence of hepatitis C virus infection in β-thalassemia patients in Pakistan: a systematic review and meta-analysis

 StudiesSampleCasesPrevalence % (95% confidence interval)I2Heterogeneityp value for Egger’s testp value for difference
Prevalence of HCV in β-thalassemia patients275789196036.2 (28.98–43.75)0.970<  0.0010.1506 
By sex       0.7978
 Male12189459234.71 (23.32–47.04)0.963<  0.00010.2923 
 Female12131636432.31 (20.17–45.75)0.952<  0.00010.2304 
By age       0.1460
 Less than 10 years997038633.87 (18.93–50.62)0.9620.09150.4417 
 10 years or above950924351.51 (34.52–68.34)0.932<  0.0010.1705 
By province       0.0573
 Punjab112113101445.98 (38.15–53.90)0.923<  0.0010.1496 
 Sindh685723631.81 (20.27–44.59)0.928<  0.0010.0922 
 Khyber Pakhtunkhwa8138636228.04 (13.58–45.26)0.976<  0.0010.3754 
By period       0.5388
 1995–2004670822341.27 (28.15–55.03)0.913< 0.00010.0050 
 2005–201412201782238.03 (28.13–48.45)0.956<  0.0010.2211 
 2015–20189306490230.66 (18.06–44.91)0.983<  0.0010.5755